CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled

Catalog No. TMPK-01005 Copy Product Info

CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled is expressed in HEK293 mammalian cells with N-His tag. The predicted molecular weight is 24.6 kDa and the accession number is Q5QGZ9-2.

CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled

Catalog No. TMPK-01005

Copy Product Info

CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled

Pack Size	Price	USA Stock	Global Stock
5 μg	$148	7-10 days	7-10 days
10 μg	$248	7-10 days	7-10 days
20 μg	$415	7-10 days	7-10 days
50 μg	$828	7-10 days	7-10 days
100 μg	$1,400	7-10 days	7-10 days
200 μg	$2,130	7-10 days	7-10 days
500 μg	$3,720	7-10 days	7-10 days

Add to Cart

Add to Quotation

In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Batch Information

Resource Download

User Guide of Recombinant Proteins

Product Information

Biological Activity	Activity has not been tested. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Description	CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled is expressed in HEK293 mammalian cells with N-His tag. The predicted molecular weight is 24.6 kDa and the accession number is Q5QGZ9-2.
Species	Human
Expression System	HEK293 Cells
Tag	N-His
Accession Number	Q5QGZ9-2
Synonyms	PRO34150,MICL,HECL,DLEC,DCAL-2,DCAL2,CLL-1,CLL1,CLECSF7,CLECSF11,CLEC12A,CD371,CD303
Construction	His65-Ala265
Protein Purity	> 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
Molecular Weight	24.6 kDa (predicted). Due to glycosylation, the protein migrates to 35-55 kDa based on Tris-Bis PAGE result.
Endotoxin	< 1.0 EU/μg of the protein as determined by the LAL method.
Formulation	Supplied as 0.22 μm filtered solution in PBS (pH 7.4).
Stability & Storage	It is recommended to store the product under sterile conditions at -70°C or lower. Samples are stable for up to 12 months at -80°C. Please avoid multiple freeze-thaw cycles and store products in aliquots.
Shipping	Proteins are shipped with blue ice.
Research Background	CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML.